THE CLINICAL COURSE OF UREMIA IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ITS IMPACT ON COMORBID PATHOLOGIES

dc.contributor.authorMaxmudova Moxidil Axmadovna
dc.date.accessioned2025-12-29T17:59:17Z
dc.date.issued2025-06-11
dc.description.abstractThis analysis explores the clinical features, underlying mechanisms, and treatment considerations of uremia in rheumatoid arthritis patients, focusing on its effects on cardiovascular, musculoskeletal, and hematologic comorbidities. Evidence shows that these patients are at higher risk for chronic kidney disease and uremic complications due to systemic inflammation, drug-related nephrotoxicity, and accelerated atherosclerosis. A comprehensive understanding of these factors is vital for effective management and improved patient outcomes.
dc.formatapplication/pdf
dc.identifier.urihttps://webofjournals.com/index.php/5/article/view/4544
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/24760
dc.language.isoeng
dc.publisherWeb of Journals Publishing
dc.relationhttps://webofjournals.com/index.php/5/article/view/4544/4498
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWeb of Medicine: Journal of Medicine, Practice and Nursing ; Vol. 3 No. 6 (2025): WOM; 43-50
dc.source2938-3765
dc.subjectUremia, rheumatoid arthritis, chronic kidney disease, nephrotoxicity, systemic inflammation, cardiovascular comorbidity, disease-modifying antirheumatic drugs.
dc.titleTHE CLINICAL COURSE OF UREMIA IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ITS IMPACT ON COMORBID PATHOLOGIES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
axmadovna_2025_the_clinical_course_of_uremia_in_patient.pdf
item.page.filesection.size
380.09 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections